Intra-cellular therapies to participate in two upcoming investor conferences

New york, oct. 31, 2023 (globe newswire) -- intra-cellular therapies, inc. (nasdaq: itci), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (cns) disorders, today announced that it will participate in two upcoming investor conferences:
ITCI Ratings Summary
ITCI Quant Ranking